TITLE

Therapeutic Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure

AUTHOR(S)
Monohar, Prerana; Pina, Ileana L.
PUB. DATE
March 2003
SOURCE
Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p334
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the effects of angiotensin II receptor blockers (ARB) on the treatment of heart failure. Renin-angiotensin system; Characteristics of ARB; Evaluation of Losartan in the elderly trial; Evaluation of strategies for left ventricular dysfunction.
ACCESSION #
9750750

 

Related Articles

  • Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Pereira, M. G.; Ferreira, J. C. B.; Bueno Jr., C. R.; Mattos, K. C.; Rosa, K. T.; Irigoyen, M. C.; Oliveira, E. M.; Krieger, J. E.; Brum, Patricia Chakur // European Journal of Applied Physiology;Apr2009, Vol. 105 Issue 6, p843 

    The role of exercise training (ET) on cardiac renin-angiotensin system (RAS) was investigated in 3–5 month-old mice lacking α2A- and α2C-adrenoceptors (α2A/α2CARKO) that present heart failure (HF) and wild type control (WT). ET consisted of 8-week running sessions of 60 min, 5...

  • CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin�angiotensin�aldosterone system the cornerstone of therapy for systolic heart failure. McMurray, John J.V. // European Journal of Heart Failure;Sep2011, Vol. 13 Issue 9, p929 

    We will shortly celebrate the 25th anniversary of the publication of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS), a clinical trial which revolutionized the treatment of heart failure and highlighted the importance of the renin�angiotensin�aldosterone system...

  • New Evidence: Treatment of Heart Failure. Alexander, Lori // MD Conference Express;Oct2012, p34 

    The article reports on the new evidence pertaining to the diagnosis and treatment of heart failure. It refers to the guideline recommendations by the European Society of Cardiology (ESC) for new medical therapies and the growing use of ventricular assist devices (VAD). Medical director Martin R....

  • Potential Contribution of Action of Renin Angiotensin System to Bone Metabolism. Nakagami, Hironori; Osako, Mariana Kiomy; Shimizu, Hideo; Hanayama, Rie; Morishita, Ryuichi // Current Hypertension Reviews;2007, Vol. 3 Issue 2, p129 

    Bone metabolism is closely regulated by hormones and cytokines, which have effects on both bone resorption and deposition. Since renin-angiotensin system (RAS) has been known to play an important role to regulate remodeling in several tissues, we focused on the potential role of RAS in bone...

  • The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice. Aartsen, Wendy M.; Schuijt, Martin P.; Danser, A.H. Jan; Daemen, Mat J.A.P.; Smits, Jos F.M. // Cardiovascular Research;Nov2002, Vol. 56 Issue 2, p205 

    Objective: Angiotensin II, generated from angiotensin I by angiotensin converting enzyme (ACE), induces multiple effects including vasoconstriction, positive cardiac inotropy, hypertrophy of cardiomyocytes and proliferation of fibroblasts. ACE exists both in a tissue-bound (t-ACE) and a...

  • The ELITE Study: What are its Implications for the Drug Treatment of Heart Failure? Aronow, W.S. // Drugs & Aging;1998, Vol. 12 Issue 6, p423 

    Angiotensin II type 1 (AT) receptor antagonists inhibit the renin-angiotensin system more completely than ACE inhibitors, and do not increase bradykinin levels as ACE inhibitors do. ACE inhibitors have been proven to increase survival and improve quality of life in patients with congestive heart...

  • New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone. Lemarié, Catherine A.; Paradis, Pierre; Schiffrin, Ernesto L. // Journal of Molecular Medicine;Jun2008, Vol. 86 Issue 6, p673 

    Angiotensin II (Ang II) is considered the main final mediator of the renin–angiotensin–aldosterone system (RAAS). The actions of Ang II have been implicated in many cardiovascular conditions, such as hypertension, atherosclerosis, coronary heart disease, restenosis after injury,...

  • Introduction. Rosivall, László; Blantz, Roland C.; Navar, L. Gabriel // Kidney International Supplement;Nov1990, Issue 30, pS-1 

    This article focuses on the increase in complexity of renin-angiotensin system. Recognition of this phenomenon has provided significant impetus to increased research activity in a variety of disciplines, and the number of scientists interested in intra-organ renin-angiotensin systems has...

  • Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Murakami, Marohito; Matsuda, Hiroto; Kubota, Eiji; Wakino, Shu; Honda, Masanori; Hayashi, Koichi; Saruta, Takao // Kidney International Supplement;Dec1997, Issue 63, pS132 

    Recent studies have provided evidence of angiotensin converting enzyme (ACE)-independent angiotensin (Ang) II formation in tissue renin-angiotensin systems. We studied the effects of Ang II generated by ACE-independent pathways on renal hemodynamics. We used a synthetic peptide, [Pro11,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics